logo Radioagência Nacional

Vacinas

Israeli drug company SciVac has developed a third-generation vaccine for the hepatitis B virus (HBV) that it believes will stem the global growth of the disease.
According to the World Health Organisation (WHO), some 600,000 people die each year from HBV, while as many as 400 million people are carriers.
icone de um fone de ouvido Áudio
icone de tempo 4:36
PNI 50 anos: saiba como as vacinas são fabricadas
ter, 12/09/2023 - 09:05
Baixar
x